GLUE Monte Rosa Therapeutics16.08-6.60 (-29.1%)
GLUE Monte Rosa Therapeutics23.85+0.82 (+3.6%)
GLUE Monte Rosa Therapeutics23.32+1.03 (+4.6%)
GLUE Monte Rosa Therapeutics24.25+8.24 (+51.5%)
After Hours Gainer
GLUE Monte Rosa Therapeutics16.01+1.61+11.2%
After Hours:17.40+1.39 (+8.7%)
Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
Globe NewswireTue, 6-Jan 4:05 PM
After Hours Gainer
GLUE Monte Rosa Therapeutics16.01+1.61+11.2%
After Hours:17.38+1.37 (+8.6%)
Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
Globe NewswireTue, 6-Jan 4:05 PM